{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:51:12Z","timestamp":1793299872748,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"25","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403279"],"award-info":[{"award-number":["82403279"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303181"],"award-info":[{"award-number":["82303181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303248"],"award-info":[{"award-number":["82303248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University"},{"name":"the Science and Technology Innovation Cultivation Fund of Zhongnan Hospital of Wuhan University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,7]]},"DOI":"10.1038\/s41388-026-03816-7","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:52:45Z","timestamp":1778496765000},"page":"2452-2465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["GBP2 enhances anti\u2013PD-L1 response in colorectal cancer via GSDMD-mediated YAP nuclear translocation by non-pyroptotic"],"prefix":"10.1038","volume":"45","author":[{"given":"Haihang","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunXiao","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3230-6077","authenticated-orcid":false,"given":"Qiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5622-966X","authenticated-orcid":false,"given":"Haizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8432-9228","authenticated-orcid":false,"given":"Fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"3816_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"L Biller","year":"2021","unstructured":"Biller L, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review[J]. JAMA-J Am Med Assoc. 2021;325:669\u201385.","journal-title":"JAMA-J Am Med Assoc"},{"key":"3816_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gie.2023.02.027","volume":"97","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Long-term outcomes of local resection versus surgical resection for high-risk T1 colorectal cancer: a systematic review and meta-analysis[J]. Gastrointest Endosc. 2023;97:29.","journal-title":"Gastrointest Endosc"},{"key":"3816_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36334-1","volume":"14","author":"J Linares","year":"2023","unstructured":"Linares J, Sallent-Aragay A, Badia-Ramentol J, Recort-Bascuas A, M\u00e9ndez A, Manero-Rup\u00e9rez N, et al. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy[J]. Nat Commun. 2023;14:18.","journal-title":"Nat Commun"},{"key":"3816_CR4","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.7150\/ijbs.64077","volume":"17","author":"A Fan","year":"2021","unstructured":"Fan A, Wang B, Wang X, Nie Y, Fan D, Zhao X, et al. Immunotherapy in colorectal cancer: current achievements and future perspective[J]. Int J Biol Sci. 2021;17:3837\u201349.","journal-title":"Int J Biol Sci"},{"key":"3816_CR5","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1084\/jem.20182031","volume":"216","author":"K Tretina","year":"2019","unstructured":"Tretina K, Park E, Maminska A, MacMicking J. Interferon-induced guanylate-binding proteins: guardians of host defense in health and disease[J]. J Exp Med. 2019;216:482\u2013500.","journal-title":"J Exp Med"},{"key":"3816_CR6","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1038\/s41388-020-1348-7","volume":"39","author":"S Yu","year":"2020","unstructured":"Yu S, Yu X, Sun L, Zheng Y, Chen L, Xu H, et al. GBP2 enhances glioblastoma invasion through Stat3\/fibronectin pathway[J]. Oncogene. 2020;39:5042\u201355.","journal-title":"Oncogene"},{"key":"3816_CR7","first-page":"17","volume":"9","author":"B Liu","year":"2021","unstructured":"Liu B, Huang R, Fu T, He P, Du C, Zhou W, et al. GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma[J]. PeerJ. 2021;9:17.","journal-title":"PeerJ"},{"key":"3816_CR8","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/mc.23447","volume":"61","author":"Y Tian","year":"2022","unstructured":"Tian Y, Wang H, Guan W, Tu X, Zhang X, Sun Y, et al. GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma[J]. Mol Carcinog. 2022;61:1082\u201398.","journal-title":"Mol Carcinog"},{"key":"3816_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12282-012-0404-8","volume":"21","author":"P Godoy","year":"2014","unstructured":"Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R, et al. Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response[J]. Breast Cancer. 2014;21:491\u20139.","journal-title":"Breast Cancer"},{"key":"3816_CR10","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/jcb.29358","volume":"121","author":"J Wang","year":"2020","unstructured":"Wang J, Min H, Hu B, Xue X, Liu Y. Guanylate-binding protein-2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel-resistant colorectal cancer cells by interfering with Wnt signaling[J]. J Cell Biochem. 2020;121:1250\u20139.","journal-title":"J Cell Biochem"},{"key":"3816_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/jitc-2021-004302","volume":"10","author":"H Wang","year":"2022","unstructured":"Wang H, et al. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target[J]. J Immunother Cancer. 2022;10:15.","journal-title":"J Immunother Cancer"},{"key":"3816_CR12","first-page":"9","volume":"4","author":"S Piccolo","year":"2023","unstructured":"Piccolo S, Panciera T, Contessotto P, Cordenonsi M. YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches[J]. Nat Cancer. 2023;4:9\u201326.","journal-title":"Nat Cancer"},{"key":"3816_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41420-021-00556-3","volume":"7","author":"J Pu","year":"2021","unstructured":"Pu J, Xu Z, Nian J, Fang Q, Yang M, Huang Y, et al. M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p\/YOD1\/YAP\/\u03b2-catenin pathway[J]. Cell Death Discov. 2021;7:14.","journal-title":"Cell Death Discov"},{"key":"3816_CR14","volume":"5","author":"O Gultekin","year":"2021","unstructured":"Gultekin O, Gonz\u00e1lez-Molina J, Hardell E, Moyano-Galceran L, Mitsios N, Mulder J, et al. FOXP3+ T cells in uterine sarcomas are associated with a favorable prognosis, low extracellular matrix expression and reduced YAP activation[J]. npj Precis Oncol. 2021;5:11.","journal-title":"npj Precis Oncol"},{"key":"3816_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1371\/journal.pbio.3000591","volume":"18","author":"E Stampouloglou","year":"2020","unstructured":"Stampouloglou E, Cheng N, Federico A, Slaby E, Monti S, Szeto GL, et al. Yap suppresses T-cell function and infiltration in the tumor microenvironment[J]. PLoS Biol. 2020;18:27.","journal-title":"PLoS Biol"},{"key":"3816_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/2326-6066.CIR-17-0320","volume":"6","author":"MH Kim","year":"2018","unstructured":"Kim MH, Kim CG, Kim SK, Shin SJ, Choe EA, Park SH, et al. YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma[J]. Cancer Immunol Res. 2018;6:255\u201366.","journal-title":"Cancer Immunol Res"},{"key":"3816_CR17","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","volume":"81","author":"M Yu","year":"2021","unstructured":"Yu M, Peng Z, Qin M, Liu Y, Wang J, Zhang C, et al. Interferon-\u03b3 induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation[J]. Mol Cell. 2021;81:1216\u201330.e1219.","journal-title":"Mol Cell"},{"key":"3816_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.celrep.2024.114003","volume":"43","author":"L Peng","year":"2024","unstructured":"Peng L, Zhou L, Li H, Zhang X, Li S, Wang K, et al. Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity[J]. Cell Rep. 2024;43:21.","journal-title":"Cell Rep"},{"key":"3816_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"3816_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-025-00837-0","volume":"26","author":"Y Bai","year":"2025","unstructured":"Bai Y, Pan Y, Liu X. Mechanistic insights into gasdermin-mediated pyroptosis[J]. Nat Rev Mol Cell Biol. 2025;26:501\u201321.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3816_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.celrep.2022.111553","volume":"41","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Yang Y, Hu Y, Yang R, Huang J, Liu Y, et al. Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockade[J]. Cell Rep. 2022;41:4.","journal-title":"Cell Rep"},{"key":"3816_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/jitc-2022-004763","volume":"10","author":"T Lv","year":"2022","unstructured":"Lv T, et al. Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression[J]. J Immunother Cancer. 2022;10:17.","journal-title":"J Immunother Cancer"},{"key":"3816_CR23","doi-asserted-by":"crossref","unstructured":"Kang M, Du W, Ding L, Wu M, Pei D. et al. HIC1 suppresses tumor progression and enhances CD8<SUP>+<\/SUP> T cells infiltration through promoting GSDMD-induced pyroptosis in gastric cancer[J]. Adv Sci 2025:12:e2412083.","DOI":"10.1002\/advs.202412083"},{"key":"3816_CR24","doi-asserted-by":"crossref","unstructured":"Zhao T, Chi Z, Wang D. Versatility of gasdermin D beyond pyroptosis[J]. Trends Cell Biol. 2025;35:1039\u201353.","DOI":"10.1016\/j.tcb.2025.02.011"},{"key":"3816_CR25","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.cell.2023.05.027","volume":"186","author":"K He","year":"2023","unstructured":"He K, Wan T, Wang D, Hu J, Zhou T, Tao W, et al. Gasdermin D licenses MHCII induction to maintain food tolerance in the small intestine[J]. Cell. 2023;186:3033\u201348.","journal-title":"Cell"},{"key":"3816_CR26","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/s41590-022-01255-6","volume":"23","author":"W Chen","year":"2022","unstructured":"Chen W, Chen S, Yan C, Zhang Y, Zhang R, Chen M, et al. Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion[J]. Nat Immunol. 2022;23:1021\u201330.","journal-title":"Nat Immunol"},{"key":"3816_CR27","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1159\/000540441","volume":"102","author":"J Zhou","year":"2024","unstructured":"Zhou J, Nie H, Yang X, Wang F, Yu P, Yu Y, et al. Ubiquitin-specific protease 52 as a prognostic biomarker correlates with tumor microenvironment and therapy response in colorectal cancer[J]. Oncology. 2024;102:1041\u201355.","journal-title":"Oncology"},{"key":"3816_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1172\/JCI153943","volume":"132","author":"DK Panda","year":"2022","unstructured":"Panda DK, Bai X, Zhang Y, Stylianesis NA, Koromilas AE, Lipman ML, Karaplis AC. SCF-SKP2 E3 ubiquitin ligase links mTORC1\/ER stress\/ISR with YAP activation in murine renal cystogenesis[J]. J Clin Investig. 2022;132:20.","journal-title":"J Clin Investig"},{"key":"3816_CR29","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1073\/pnas.1019603108","volume":"108","author":"H Zhang","year":"2011","unstructured":"Zhang H, Pasolli H, Fuchs E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin[J]. Proc Natl Acad Sci USA. 2011;108:2270\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3816_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ajpath.2013.12.017","volume":"184","author":"T Quan","year":"2014","unstructured":"Quan T, Xu Y, Qin Z, Robichaud P, Betcher S, Calderone K, et al. Elevated YAP and its downstream targets CCN1 and CCN2 in basal cell carcinoma impact on keratinocyte proliferation and stromal cell activation[J]. Am J Pathol. 2014;184:937\u201343.","journal-title":"Am J Pathol"},{"key":"3816_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41590-020-0697-2","volume":"21","author":"MP Wandel","year":"2020","unstructured":"Wandel MP, Kim BH, Park ES, Boyle KB, Nayak K, Lagrange B, et al. Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms[J]. Nat Immunol. 2020;21:880\u201391.","journal-title":"Nat Immunol"},{"key":"3816_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1073\/pnas.2216028120","volume":"120","author":"MS Dickinson","year":"2023","unstructured":"Dickinson MS, Kutsch M, Sistemich L, Hernandez D, Piro AS, Needham D, et al. LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro[J]. Proc Natl Acad Sci USA. 2023;120:12.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3816_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04187-3","volume":"21","author":"WQ Feng","year":"2023","unstructured":"Feng WQ, Zhang YC, Xu ZQ, Yu SY, Huo J, Tuersun A, et al. IL-17A-mediated mitochondrial dysfunction induces pyroptosis in colorectal cancer cells and promotes CD8+ T-cell tumor infiltration[J]. J Transl Med. 2023;21:17.","journal-title":"J Transl Med"},{"key":"3816_CR34","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1038\/s41388-022-02397-5","volume":"41","author":"H Xu","year":"2022","unstructured":"Xu H, Jin J, Chen Y, Wu G, Zhu H, Wang Q, et al. GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair[J]. Oncogene. 2022;41:3876\u201385.","journal-title":"Oncogene"},{"key":"3816_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05984-0","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, Chen J, Liang H, Du Q, Shen J, Wang X. Gasdermin D regulates the activation of EGFR in colorectal cancer[J]. J Transl Med. 2024;22:1.","journal-title":"J Transl Med"},{"key":"3816_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-025-00249-8","volume":"6","author":"Y Li","year":"2025","unstructured":"Li Y, Guo B. GSDMD-mediated pyroptosis: molecular mechanisms, diseases and therapeutic targets[J]. Mol Biomed. 2025;6:25.","journal-title":"Mol Biomed"},{"key":"3816_CR37","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.2147\/DDDT.S456783","volume":"18","author":"W Fu","year":"2024","unstructured":"Fu W, Cao Y, Liu J, Huang C, Shu K, Zhu N. Xinfeng Capsule Inhibits Pyroptosis and Ameliorates Myocardial Injury in Rats with Adjuvant Arthritis via the GAS5\/miR-21\/TLR4 Axis[J]. Drug Des Dev Ther. 2024;18:2421\u201333.","journal-title":"Drug Des Dev Ther"},{"key":"3816_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","volume":"63","author":"R Tokunaga","year":"2018","unstructured":"Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy[J]. Cancer Treat Rev. 2018;63:40\u20137.","journal-title":"Cancer Treat Rev"},{"key":"3816_CR39","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1073\/pnas.1718217115","volume":"115","author":"E Ahn","year":"2018","unstructured":"Ahn E, Araki K, Hashimoto M, Li W, Riley JL, Cheung J, et al. Role of PD-1 during effector CD8 T cell differentiation[J]. Proc Natl Acad Sci USA. 2018;115:4749\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3816_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03872-7","volume":"21","author":"RH Huang","year":"2023","unstructured":"Huang RH, Hong YK, Du H, Ke WQ, Lin BB, Li YL. CHSY3 promotes proliferation and migration in gastric cancer and is associated with immune infiltration[J]. J Transl Med. 2023;21:20.","journal-title":"J Transl Med"},{"key":"3816_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3892\/ijo.2024.5622","volume":"64","author":"W Zhang","year":"2024","unstructured":"Zhang W, Tang X, Peng Y, Xu Y, Liu L, Liu S. GBP2 enhances paclitaxel sensitivity in triple-negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K\/AKT\/mTOR pathway[J]. Int J Oncol. 2024;64:18.","journal-title":"Int J Oncol"},{"key":"3816_CR42","first-page":"772","volume":"51","author":"G Ji","year":"2021","unstructured":"Ji G, Luo B, Chen L, Shen G, Tian T. GBP2 is a favorable prognostic marker of skin cutaneous melanoma and affects its progression via the Wnt\/\u03b2-catenin pathway[J]. Ann Clin Lab Sci. 2021;51:772\u201382.","journal-title":"Ann Clin Lab Sci"},{"key":"3816_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3892\/or.2023.8673","volume":"49","author":"S Ye","year":"2023","unstructured":"Ye S, Li S, Qin L, Zheng W, Liu B, Li X, et al. GBP2 promotes clear cell renal cell carcinoma progression through immune infiltration and regulation of PD-L1 expression via STAT1 signaling[J]. Oncol Rep. 2023;49:14.","journal-title":"Oncol Rep"},{"key":"3816_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41420-022-01018-0","volume":"8","author":"Y Ren","year":"2022","unstructured":"Ren Y, Yang B, Guo G, Zhang J, Sun Y, Liu D, et al. GBP2 facilitates the progression of glioma via regulation of KIF22\/EGFR signaling[J]. Cell Death Discov. 2022;8:9.","journal-title":"Cell Death Discov"},{"key":"3816_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10488-5","volume":"23","author":"M Tsuneki","year":"2023","unstructured":"Tsuneki M, Abe M, Ichihara S, Kanavati F. GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer[J]. BMC Cancer. 2023;23:11.","journal-title":"BMC Cancer"},{"key":"3816_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/advs.202412881","volume":"12","author":"J Xiong","year":"2025","unstructured":"Xiong J, Huang J, Xu H, Wu Q, Zhao J, Chen Y, et al. CpG-based nanovaccines enhance ovarian cancer immune response by Gbp2-mediated remodeling of tumor-associated macrophages[J]. Adv Sci. 2025;12:16.","journal-title":"Adv Sci"},{"key":"3816_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00262-024-03786-3","volume":"73","author":"Y Tasiheng","year":"2024","unstructured":"Tasiheng Y, Lin X, Wang X, Zou X, Chen Y, Yan Y, et al. DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancer[J]. Cancer Immunol Immunother. 2024;73:17.","journal-title":"Cancer Immunol Immunother"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03816-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03816-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03816-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:10:28Z","timestamp":1781561428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03816-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":47,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026,7,7]]}},"alternative-id":["3816"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03816-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Research Ethics Committee of Zhongnan Hospital of Wuhan University, and written informed consent was obtained from all participants in accordance with the Declaration of Helsinki (grant no. 2025001\u2009K). All the methods were carried out in accordance with the relevant guidelines under the ethical approval and consent to participate section. Data collection, analysis, and reporting were conducted following the REMARK guidelines for tumor marker prognostic studies. The study protocol, including animal experiments, was approved by the Institutional Animal Care and Use Committee of Wuhan University (WP20240225).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}